Sandoz (OTCQX: sdzny) Monday told that pyzchiva (ustekinumab-ttwe) is now commercially available to patients across the US
Developed by Samsung Biopiration Co., and commercialized by Sandoz, Pyzchiva approved American food and drugs, to treat certain chronic inflammatory chronic